查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2130865

胃腸道糞便檢驗市場分析及預測（至2035年）：類型、產品、服務、技術、應用、流程、最終用戶、方法論

GI Stool Testing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Process, End User, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球胃腸道糞便檢驗市場預計將從2025年的3.774億美元成長到2035年的7.634億美元，複合年成長率（CAGR）為7.3%。推動糞便檢驗市場成長的因素包括：對準確檢測胃腸道感染疾病的需求、分子診斷技術的日益普及以及對快速識別細菌、病毒和寄生蟲等病原體的需求。 2026年2月，美國疾病管制與預防中心（CDC）指出，連續糞便檢驗仍是類絛蟲病診斷的黃金標準，強調了糞便檢驗持續重要的臨床意義。此外，CDC在2025年4月發布的指南中強調了糞便檢驗在寄生蟲疾病診斷中的重要性，包括卵母細胞寄生蟲疾病和抗原檢測。多重PCR、抗原檢測和自動化診斷分析技術的進步正在提高診斷速度和病原體識別的準確性。

胃腸道糞便檢驗市場可細分為多種類型，包括免疫檢測、分子檢測、層析法、培養法、顯微鏡檢查等。預計到2025年，免疫檢測將佔市場主導地位，這主要得益於其廣泛的應用、成本效益、快速出結果以及在消化器官系統感染疾病和生物標記檢測方面成熟的應用經驗。分子檢測預計將成為預測期內成長最快的細分市場，這主要得益於基於PCR的檢測方法的日益普及、靈敏度和特異性的提高、多種病原體的檢測以及對快速準確診斷日益成長的需求。雖然培養法和顯微鏡檢查仍繼續支持傳統的診斷流程，但層析法和其他先進技術在專業的糞便分析和生物標記檢測方面正日益受到重視。

市場區隔
類型 免疫檢測、分子檢測、層析法、培養法、顯微鏡檢查等。
產品 試劑、試劑盒、設備、耗材及其他
服務 臨床實驗室服務、即時檢驗實驗室服務、諮詢服務等。
科技 PCR、ELISA、質譜、次世代定序等。
目的 感染疾病檢測、癌症篩檢、發炎性疾病、營養缺乏症等。
流程 檢體採集、檢體製備、分析、結果報告及其他相關任務。
最終用戶 醫院、診斷檢驗實驗室、研究機構、居家照護及其他
方法 自動、半自動、手動、其他

胃腸道糞便檢測市場的終端使用者包括醫院、診斷實驗室、研究機構、家庭護理機構及其他機構。由於患者數量龐大、診斷基礎設施完善以及對胃腸道感染和疾病診斷的需求不斷增長，預計醫院將在2025年佔市場主導地位。家庭護理機構預計將成為預測期內成長最快的細分市場，這得益於人們對便捷檢測、居家樣本採集、遠距醫療服務的需求不斷增長，以及消費者對消化系統健康監測日益增長的興趣。診斷實驗室憑藉其專業的檢測能力和外包趨勢，繼續發揮重要作用，而研究機構則正在擴大糞便檢測在胃腸道疾病研究和微生物組研究中的應用。

區域概覽

預計到2025年，北美將成為胃腸道糞便檢驗市場最大的地區。這主要得益於先進的醫療基礎設施、完善的臨床檢查室網路、高額的醫療費用支出以及分子和免疫檢測分析診斷技術的廣泛應用。該地區受益於成熟的結直腸癌篩檢計畫、較高的消化系統疾病認知度、便捷的診斷服務以及非侵入性糞便檢驗的日益普及。美國憑藉著廣泛的醫療保險覆蓋和先進的診斷設施，成為該地區需求的主要驅動力。

在預測期內，亞太地區預計將成為胃腸道糞便檢驗市場成長最快的地區，這主要得益於醫療基礎設施的不斷完善、醫療支出的持續成長、人們對胃腸道疾病認知的提高以及先進診斷技術的普及。中國、印度、日本和韓國等國家預計將顯著推動區域市場擴張，因為這些國家能夠更便捷地獲得診斷服務，並且對早期、準確的疾病檢測需求不斷成長。胃腸道感染疾病和其他消化系統疾病的日益普遍，以及各國政府為加強醫療衛生體系和診斷能力所做的努力，預計將進一步促進糞便檢驗在全部區域。

主要趨勢和促進因素

向多分子檢測和基於微生物組的糞便檢驗過渡：

胃腸道糞便檢驗市場正日益從傳統的培養、顯微鏡檢查和單一分析轉向多重PCR、症候群特異性分子檢測和微生物組分析。多重PCR平台能夠同時從單一糞便檢體中識別細菌、病毒和寄生蟲病原體，從而縮短檢測時間並實現更有針對性的治療。同時，次世代定序技術正在拓展糞便分析的範圍，使其超越病原體檢測，擴展到腸內菌叢菌群及其失衡的表徵，從而支持個人化胃腸道醫療。這一趨勢的驅動力也來自於臨床上對快速症候群特異性檢測日益成長的需求，尤其是在急性感染性腹瀉和複雜胃腸道症狀患者中。

對非侵入性檢測胃腸道疾病和大腸直腸癌的需求日益成長：

胃腸道糞便檢測市場的主要驅動因素是非侵入性糞便診斷技術在結直腸癌篩檢、發炎性腸道疾病和胃腸道感染診斷的應用日益廣泛。糞便免疫化學檢測 (FIT) 和其他糞便隱血試驗為檢測與結直腸異常相關的胃腸道出血提供了一種便捷的篩檢方法，而糞鈣衛蛋白和乳鐵蛋白檢測則有助於區分發炎性腸道疾病和功能性疾病，並可減少不必要的侵入性檢查。大腸直腸癌篩檢計畫的發展、胃腸道疾病發生率的上升以及對疾病早期發現的需求，都推動了檢測量的增長。同時，多重分子檢測技術也增加了對急性胃腸炎病原體快速鑑定的需求。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 免疫檢測
    • 分子檢測
    • 層析法
    • 基於培養方法的測試
    • 顯微鏡檢查
    • 其他
  • 市場規模及預測：依產品分類
    • 試劑
    • 成套工具
    • 裝置
    • 消耗品
    • 其他
  • 市場規模及預測：依服務分類
    • 臨床實驗室服務
    • 即時檢測服務
    • 諮詢服務
    • 其他
  • 市場規模及預測：依技術分類
    • PCR
    • ELISA
    • 質譜分析
    • 次世代定序
    • 其他
  • 市場規模及預測：依應用領域分類
    • 感染疾病檢測
    • 癌症篩檢
    • 發炎性疾病
    • 營養缺乏
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷檢測實驗室
    • 研究所
    • 居家照護
    • 其他
  • 市場規模及預測：依製程分類
    • 檢體採集
    • 檢體製備
    • 分析
    • 檢查報告
    • 其他
  • 市場規模及預測：依方法論分類
    • 自動的
    • 半自動
    • 手動的
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Roche Diagnostics
  • Danaher Corporation
  • Becton Dickinson and Company
  • Quest Diagnostics
  • Siemens Healthineers
  • PerkinElmer
  • bioMerieux
  • Hologic
  • DiaSorin
  • Luminex Corporation
  • Genova Diagnostics
  • Promega Corporation
  • Randox Laboratories
  • Alere
  • EKF Diagnostics
  • Meridian Bioscience

第9章 關於我們

簡介目錄
Product Code: GIS10603

The global GI Stool Testing Market is projected to grow from $377.4 million in 2025 to $763.4 million by 2035, at a compound annual growth rate (CAGR) of 7.3%. The GI Stool Testing Market is driven by the need for accurate detection of gastrointestinal infections, increasing use of molecular diagnostics, and demand for rapid identification of bacterial, viral, and parasitic pathogens. In February 2026, the CDC stated that serial stool examination remains the gold standard for diagnosing Strongyloides infection, highlighting the continued clinical importance of stool-based testing. In April 2025, CDC guidance also emphasized stool testing for parasitic diseases, including ova-and-parasite and antigen-based methods. Advances in multiplex PCR, antigen detection, and automated laboratory analysis are improving diagnostic speed and pathogen identification.

The Type segment of the GI Stool Testing Market includes Immunoassay Testing, Molecular Testing, Chromatography, Culture-Based Testing, Microscopy, and Others. Immunoassay Testing dominated the market in 2025 due to its widespread use, cost-effectiveness, rapid results, and established application in detecting gastrointestinal infections and biomarkers. Molecular Testing is expected to be the fastest-growing segment during the forecast period, driven by increasing adoption of PCR-based testing, higher sensitivity and specificity, multiplex pathogen detection, and growing demand for rapid and accurate diagnosis. Culture-Based Testing and Microscopy continue to support conventional diagnostic workflows, while chromatography and other advanced techniques are gaining attention for specialized stool analysis and biomarker detection.

Market Segmentation
TypeImmunoassay Testing, Molecular Testing, Chromatography, Culture-Based Testing, Microscopy, Others
ProductReagents, Kits, Instruments, Consumables, Others
ServicesLaboratory Testing Services, Point-of-Care Testing Services, Consultation Services, Others
TechnologyPCR, ELISA, Mass Spectrometry, Next-Generation Sequencing, Others
ApplicationInfectious Disease Detection, Cancer Screening, Inflammatory Conditions, Nutritional Deficiencies, Others
ProcessSample Collection, Sample Preparation, Analysis, Reporting, Others
End UserHospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings, Others
ModeAutomated, Semi-Automated, Manual, Others

The End User segment of the GI Stool Testing Market includes Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others. Hospitals dominated the market in 2025 due to high patient volumes, established diagnostic infrastructure, and increasing demand for gastrointestinal infection and disease diagnosis. Home Care Settings are expected to be the fastest-growing segment during the forecast period, supported by rising demand for convenient testing, at-home sample collection, remote healthcare services, and increased consumer interest in digestive health monitoring. Diagnostic Laboratories continue to play an important role due to specialized testing capabilities and outsourcing trends, while Research Institutes are expanding their use of stool testing for gastrointestinal disease research and microbiome studies.

Geographical Overview

North America was the leading region in the GI Stool Testing Market in 2025, supported by advanced healthcare infrastructure, well-established clinical laboratory networks, high healthcare spending, and widespread adoption of molecular and immunoassay-based diagnostic technologies. The region benefited from established colorectal cancer screening programs, strong awareness of gastrointestinal disorders, favorable access to diagnostic services, and increasing use of non-invasive stool-based testing. The United States represented the major contributor to regional demand, supported by extensive healthcare coverage and the presence of sophisticated diagnostic facilities.

Asia-Pacific is expected to be the fastest-growing region in the GI Stool Testing Market during the forecast period, driven by expanding healthcare infrastructure, rising healthcare expenditure, increasing awareness of gastrointestinal diseases, and growing adoption of advanced diagnostic technologies. Countries such as China, India, Japan, and South Korea are expected to contribute significantly to regional expansion as access to diagnostic services improves and demand for early and accurate disease detection increases. The rising prevalence of gastrointestinal infections and other digestive disorders, together with government initiatives to strengthen healthcare systems and diagnostic capabilities, is expected to further support the adoption of stool testing across the regio

Key Trends and Drivers

Shift Toward Multiplex Molecular and Microbiome-Based Stool Testing:

The GI Stool Testing Market is increasingly shifting from conventional culture, microscopy, and single-analyte assays toward multiplex PCR, syndromic molecular panels, and microbiome profiling. Multiplex PCR platforms can simultaneously identify bacterial, viral, and parasitic pathogens from a single stool specimen, reducing turnaround time and enabling more targeted treatment. At the same time, next-generation sequencing is expanding stool analysis beyond pathogen detection toward characterization of gut microbiota and dysbiosis, supporting personalized gastroenterology. The trend is also being reinforced by increasing clinical interest in rapid syndromic testing, particularly for patients with acute infectious diarrhea and complex gastrointestinal symptoms.

Rising Demand for Non-Invasive Detection of GI Disorders and Colorectal Cancer:

A major driver of the GI Stool Testing Market is the growing use of non-invasive stool-based diagnostics for colorectal cancer screening, inflammatory bowel disease, and gastrointestinal infections. FIT and other fecal occult-blood tests provide an accessible screening option for detecting gastrointestinal bleeding associated with colorectal abnormalities, while fecal calprotectin and lactoferrin help differentiate inflammatory bowel disease from functional disorders and can reduce unnecessary invasive investigations. Increasing colorectal cancer screening programs, growing incidence of GI disorders, and the need for earlier disease detection are expanding testing volumes. At the same time, multiplex molecular assays are increasing demand for rapid pathogen identification in acute gastroenteritis.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Immunoassay Testing
    • 4.1.2 Molecular Testing
    • 4.1.3 Chromatography
    • 4.1.4 Culture-Based Testing
    • 4.1.5 Microscopy
    • 4.1.6 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents
    • 4.2.2 Kits
    • 4.2.3 Instruments
    • 4.2.4 Consumables
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Laboratory Testing Services
    • 4.3.2 Point-of-Care Testing Services
    • 4.3.3 Consultation Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 PCR
    • 4.4.2 ELISA
    • 4.4.3 Mass Spectrometry
    • 4.4.4 Next-Generation Sequencing
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Infectious Disease Detection
    • 4.5.2 Cancer Screening
    • 4.5.3 Inflammatory Conditions
    • 4.5.4 Nutritional Deficiencies
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Research Institutes
    • 4.6.4 Home Care Settings
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Sample Collection
    • 4.7.2 Sample Preparation
    • 4.7.3 Analysis
    • 4.7.4 Reporting
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Mode (2020-2035)
    • 4.8.1 Automated
    • 4.8.2 Semi-Automated
    • 4.8.3 Manual
    • 4.8.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Bio-Rad Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Qiagen
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Roche Diagnostics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Danaher Corporation
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Becton Dickinson and Company
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Quest Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Siemens Healthineers
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 PerkinElmer
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 bioMerieux
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Hologic
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 DiaSorin
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Luminex Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Genova Diagnostics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Promega Corporation
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Randox Laboratories
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Alere
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 EKF Diagnostics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Meridian Bioscience
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us